Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Krakowska im. Tadeusza KościuszkifiledCriticalPolitechnika Krakowska im. Tadeusza Kościuszki
Priority to PL418917ApriorityCriticalpatent/PL230996B1/en
Priority to PCT/PL2017/000070prioritypatent/WO2018063010A1/en
Publication of PL418917A1publicationCriticalpatent/PL418917A1/en
Publication of PL230996B1publicationCriticalpatent/PL230996B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Przedmiotem zgłoszenia jest nowa, pochodna lupeolu, o nazwie chemicznej ester kwasu 3-pikolinowego i 20(29)-lupen-3ß-olu, o wzorze 1, będąca estrem pozyskanym w wyniku modyfikacji struktury naturalnego lupeolu o wzorze 2, chlorkiem kwasu 3-pikolinowego o wzorze 3 lub kwasem 3-pikolinowym o wzorze 4.The subject of the application is a new, lupeol derivative, with the chemical name 3-picolinic acid ester and 20 (29) -lupen-3ß-ol, of formula 1, which is an ester obtained as a result of modification of the structure of the natural lupeol of formula 2, with 3-picolinic acid chloride of formula 3 or 3-picolinic acid of formula 4.
PL418917A2016-09-292016-09-29New derivative of lupeol
PL230996B1
(en)
2,4-dimethoxybenzylamide of 5-(1-ethoxyethylideneamino)-3-methyl-4-isoxazole carboxylic acid with immunomodulatory and anti-inflamatory activities and method for producing it and application